LICN — Lichen International Cashflow Statement
0.000.00%
- $2.17m
- -$20.40m
- $41.48m
Annual cashflow statement for Lichen International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6.41 | 8.46 | 7.82 | 8.34 | -6.12 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.087 | 0.063 | 0.122 | 0.164 | 3.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.304 | -3.67 | 0.217 | -10.8 | -5.85 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8.35 | 7.3 | 10.8 | 0.557 | -5.57 |
| Capital Expenditures | -1.16 | -0.028 | -2.84 | -5.27 | -9.75 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.589 | 0 | -4.6 | -0.14 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.16 | 0.561 | -2.84 | -9.87 | -9.89 |
| Financing Cash Flow Items | -4.35 | 0 | — | — | 0.866 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.35 | 0 | -0.327 | 14.1 | 13.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.27 | 8.18 | 5.75 | 3.26 | 0.856 |